血小板激活在急性冠脉综合征的发生中起重要的作用。抑制血小板聚集药物治疗可以抑制血小板的粘附、聚集和释放功能,从而抑制血栓形成。然而,抑制血小板聚集药物的作用个体差异很大。有的患者对抑制血小板聚集药物存在抵抗现象,尽管长期服用常规剂量的药物,但仍发生血栓栓塞事件或实验室检测发现其血小板聚集能力不能被很好地 Platelet activation plays an important role in the development of acute coronary syndrome. Inhibition of platelet aggregation Drug treatment can inhibit platelet adhesion, aggregation and release of the function, thereby inhibiting thrombosis. However, the role of agents that inhibit platelet aggregation varies widely among individuals. Some patients on the inhibition of platelet aggregation drug resistance phenomenon, despite the long-term use of conventional doses of drugs, but still thromboembolic events or laboratory tests found that its ability to platelet aggregation can not be very good